YNU

eplerenone

Find entries where: YNU

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	eplerenone
Formula	C₂₄ H₃₀ O₆
Molecular Weight	414.491
Type	NON-POLYMER
Isomeric SMILES	C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC
InChI	InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1
InChIKey	JUKPWJGBANNWMW-VWBFHTRKSA-N

Chemical Details
Formal Charge	0
Atom Count	60
Chiral Atom Count	8
Bond Count	65
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00700
Name	Eplerenone
Groups	approved
Description	Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.
Synonyms	Epoxymexrenone Eplerenone Eplerenona
Brand Names	Jamp Eplerenone Eplerenone Mint-eplerenone Inspra Gd-eplerenone Apo-eplerenone
Indication	For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction.
Categories	Agents causing hyperkalemia Antihypertensive Agents Antihypertensive Agents Indicated for Hypertension Cardiovascular Agents Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Substrates Diuretics Fused-Ring Compounds Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Hypotensive Agents Lactones Mineralocorticoid (Aldosterone) Receptor Antagonists Mineralocorticoid Receptor Antagonists Natriuretic Agents Potassium-Sparing Diuretics Pregnanes Pregnenes Steroids
ATC-Code	C03DA04
CAS number	107724-20-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Mineralocorticoid receptor	METKGYHSLPEGLDMERRWGQVSQAVERSSLGPTERTDENNYMEIVNVSC...	unknown	antagonist
Cytochrome P450 11B2, mitochondrial	MALRAKAEVCVAAPWLSLQRARALGTRAARAPRTVLPFEAMPQHPGNRWL...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682